CN
464-43-7
应用筛选条件
关键词:'464-43-7'
显示 1-30 共 32 条结果 关于 "464-43-7" 范围 技术文档
Data Sheet - A2101
Anti-Amyloid Peptide β, Cleavage Site 43 (Aβ43) is
developed in rabbit using as immunogen a synthetic
peptide of approximately 7-10 amino acid residues at
the C-terminus of Aβ 43. The antibody is cleavage site
Data Sheet - A1976
, 1-31
(2002).
7. Lorenzo, A., et al., Amyloid β interacts with the
amyloid precursor protein: a potential toxic
mechanism in Alzheimer's disease. Nat. Neurosci.,
3, 460-464 (2000).
AH
Caspase 8 human (C1099)
-4 and MCH5) have been described at the
mRNA level.
7
The predominant caspase-8 isoforms expressed in
cells, caspase 8a/b (479 and 464 aa), are formed as
inactive 55 kDa and 54 kDa precursors
Data Sheet - A3483 - Lot 119K0849
The Aurora kinases: role in cell
transformation and tumorigenesis. Cancer
Metastasis Rev., 22, 451-464 (2003).
Precisio is a trademark of Sigma-Aldrich
Biotechnology LP and Sigma-Aldrich Co.
TLD
Data Sheet - A3483
The Aurora kinases: role in cell
transformation and tumorigenesis. Cancer
Metastasis Rev., 22, 451-464 (2003).
PRECISIO is a registered trademark of Sigma-Aldrich
Co. LLC.
JR,JB,MAM 10/12-1
2012
Data Sheet - A3483 - Lot 019K0636
The Aurora kinases: role in cell
transformation and tumorigenesis. Cancer
Metastasis Rev., 22, 451-464 (2003).
TLD,MAM 02/09-1
Sigma brand products are sold through Sigma-Aldrich, Inc.
Sigma-Aldrich
Data Sheet - H6661
Science, 292, 464-468 (2001).
6. Bruick, R.K., Expression of the gene encoding the
proapoptotic Nip3 protein is induced by hypoxia.
Proc. Nat. Acad. Sci. USA, 97, 9082-9087 (2000).
7. Epstein, A.
Data Sheet - H6411
Science, 292, 464-468 (2001).
6. Bruick, R.K., Expression of the gene encoding the
proapoptotic Nip3 protein is induced by hypoxia.
Proc. Nat. Acad. Sci. USA, 97, 9082-9087 (2000).
7. Epstein, A
Data Sheet - H6536
Science, 292, 464-468 (2001).
6. Bruick, R.K., Expression of the gene encoding the
proapoptotic Nip3 protein is induced by hypoxia.
Proc. Nat. Acad. Sci. USA, 97, 9082-9087 (2000).
7. Epstein, A.C.R
XP725 Antibody Number-Lot Number 071M4826
74 75 76
1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80
1.3 9 10 11 12 33 34 35 36 57 58 59 60 81 82 83 84
1.4 13 14 15 16 37
Product Information Sheet - E7637
2nd ed., (Cold Spring Harbor
Laboratory, 1989), p 6.15, 6.44 etc.
7. Le Pecq, J.-B., in Methods of Biochemical Analysis,
20, 43-86.
8. Bechtol, K.B. et al., American Biotechnology Lab,
p. 8, December
Product Information Sheet - E1385
2nd ed., (Cold Spring Harbor
Laboratory, 1989), p 6.15, 6.44 etc.
7. Le Pecq, J.-B., in Methods of Biochemical Analysis,
20, 43-86.
8. Bechtol, K.B. et al., American Biotechnology Lab,
p. 8, December
Product Information Sheet - BE0100
amyloid precursor protein: a potential toxic
mechanism in Alzheimer's disease. Nat. Neurosci.,
3, 460-464 (2000).
5. Sambamurti, K., et al. Advances in the cellular and
molecular biology of the β-amyloid
BE0100-Amyloid 1-40 ELISA Human AHPHC
amyloid precursor protein: a potential toxic
mechanism in Alzheimer's disease. Nat. Neurosci.,
3, 460-464 (2000).
5. Sambamurti, K., et al. Advances in the cellular and
molecular biology of the β-amyloid
BE0200-Amyloid 1-42 ELISA Human AHPHC
amyloid precursor protein: a potential toxic
mechanism in Alzheimer's disease. Nat. Neurosci.,
3, 460-464 (2000).
5. Sambamurti, K., et al., Advances in the cellular and
molecular biology of the β-amyloid
Product Information Sheet - BE0200
amyloid precursor protein: a potential toxic
mechanism in Alzheimer's disease. Nat. Neurosci.,
3, 460-464 (2000).
5. Sambamurti, K., et al., Advances in the cellular and
molecular biology of the β-amyloid
Impurities & Related Compounds: Reference Materials
112-61-8
13614-98-7
141-43-5
51481-60-8
550-99-2
243116-62-3
104206-65-7
72078-82-1
68-22-4
35189-28-7
760-78-1
79517-01-4
204255-11-8
11018-89-6
112529-15-4
Balancing Histone/Protein Acetylation-Gene Regulation and Cancer Therapy
59. Davie, J.R., J. Nutr., 133, 2485S-2493S (2003).
60. Riggs, M.G., et al., Nature, 268, 462-464 (1977).
61. Lau, O.D., et al., Mol. Cell, 5, 589-595 (2000).
62. Cebrat, M., et al., Bioorg. Med
Cytoskeletal Signaling Antibodies, Reagents and Kits
ELISA APur Rb 50 µg AB1726
Connexin 43 M R B WB IP APur Rb 50 µg AB1727
ELISA IC
Connexin 43 H M R WB IP APur Rb 50 µg AB1728
ELISA IF IH
XP725 Antibody List Lot 129K4831
465 MTA 2 M7569 9219 MTA2 M NP_004730.2 y y y
468 MTA2/MTA1L M7818 9219 MTA2 P NP_004730.2 y n/d n/d
464 MSK-1 M5437 9252 RPS6KA5 P NP_004746.2 n/d n/d y
426 MAP Kinase Activated Protein Kinase-2 (MAPKAPK
XP725 Antibody List Lot 129K4830
465 MTA 2 M7569 9219 MTA2 M NP_004730.2 y y y
468 MTA2/MTA1L M7818 9219 MTA2 P NP_004730.2 y n/d n/d
464 MSK-1 M5437 9252 RPS6KA5 P NP_004746.2 n/d n/d y
426 MAP Kinase Activated Protein Kinase-2 (MAPKAPK
XP725 Antibody List Lot 089K4791
465 MTA 2 M7569 9219 MTA2 M NP_004730.2 y y y
468 MTA2/MTA1L M7818 9219 MTA2 P NP_004730.2 y n/d n/d
464 MSK-1 M5437 9252 RPS6KA5 P NP_004746.2 n/d n/d y
426 MAP Kinase Activated Protein Kinase-2 (MAPKAPK
Cellutions Newsletter: 2008, Volume 3
., Hasneen K., machacek D.W., Boyd N.l., Rao R.R., Stice S.l.
(2008). Differentiation. 76(5): 454-464.
3. Cukierman e., Pankov R., Stevens D.R., Yamada K.m. (2001). Science.
94:1708-383.
4. Wolf
Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation
A
U
Time (min)
7 mL/min 19 mL/min 43 mL/min
Time (min) Time (min)
2
3
4
5
6
7
8
9
10
11
0
0
XP725 Worksheet for Lot Number 071M4826
3 DP2 D7438
460 3 2 4 4 DP2 D7438
461 3 2 4 5 DR3 D3563
462 3 2 4 6 DR3 D3563
463 3 2 4 7 Negative Control NA
464 3 2 4 8 Negative Control NA
465 3 2 5 1 DR4
List of Antibodies
MRP2 M3692 M y n/d n/d
461 α-MSH M0939 P y n/d n/d
462 MSH6 M2445 P y y y
463 MSH6 M2820 P y y n/d
464 MSK-1 M5437 P y n/d y
465 MTA 2 M7569 M y y y
466 MTA1 M1320 M
3D BIOPRINTING: Printing a Brighter Future
Greenfield, P. T.; Calafat, N. J.; Gounley, J. P.; Ta, A. H.; et
al. Science 2019, 364 (6439), 458–464.
(14) Levato, R.; Lim, K. S.; Li, W.; Asua, A. U.; Peña, L. B.; Wang, M.;
Falandt, M.; Bernal
3D BIOPRINTING: Printing a Brighter Future
Greenfield, P. T.; Calafat, N. J.; Gounley, J. P.; Ta, A. H.; et
al. Science 2019, 364 (6439), 458–464.
(14) Levato, R.; Lim, K. S.; Li, W.; Asua, A. U.; Peña, L. B.; Wang, M.;
Falandt, M.; Bernal
XP725 Antibody List
/d n/d
462 MSH6 M2445 2956 MSH6 NP_000170.1 P y y y
463 MSH6 M2820 2956 MSH6 NP_000170.1 P y y n/d
464 MSK-1 M5437 445349, 9252 RPS6KA5,Rps6ka5 ,NP_872198.1 P y n/d y
465 MTA 2 M7569 361724, 23942, 9219
XP725 Antibody List 013M4793
/d n/d
462 MSH6 M2445 2956 MSH6 NP_000170.1 P y y y
463 MSH6 M2820 2956 MSH6 NP_000170.1 P y y n/d
464 MSK-1 M5437 445349, 9252 RPS6KA5,Rps6ka5 ,NP_872198.1 P y n/d y
465 MTA 2 M7569 361724, 23942, 9219
1/2